Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation (Details Textual)

v3.4.0.3
Basis of Presentation (Details Textual) - USD ($)
 1 Months Ended 9 Months Ended
May. 15, 2015
Apr. 30, 2016
Apr. 13, 2016
Jan. 25, 2016
Mar. 31, 2016
Mar. 31, 2015
Jun. 30, 2015
Jun. 30, 2014
Basis of Presentation [Line Items]                
Accumulated deficit         $ (54,914,000)   $ (47,827,000)  
Net Cash Used in Operating Activities         (5,250,000) $ (3,518,000)    
Stock Issued During Period, Value, New Issues         2,178,000      
Cash and Cash Equivalents, at Carrying Value, Total         $ 21,893,000 $ 8,080,000 $ 9,494,000 $ 3,590,000
Common Stock, Par or Stated Value Per Share         $ 0.001   $ 0.001  
Class Of Warrants Or Rights Exercised         1,904,000      
Class of Warrant or Right, Exercise Price of Warrants or Rights         $ 0.53   $ 1.38  
Subsequent Event [Member]                
Basis of Presentation [Line Items]                
Stock Issued During Period, Shares, New Issues   6,500,000 6,500,000          
Stock Issued During Period, Value, New Issues   $ 4,000,000 $ 4,043,000          
Subsequent Event [Member] | Stockholders [Member]                
Basis of Presentation [Line Items]                
Stock Issued During Period, Shares, Other   6,500,000            
Aspire Capital Fund Llc [Member]                
Basis of Presentation [Line Items]                
Stock Issued During Period, Value, New Issues $ 500,000              
Stock Issued During Period, Shares, Other 200,000              
Aspire Capital Fund Llc [Member] | Maximum [Member]                
Basis of Presentation [Line Items]                
Sale of Stock, Consideration Received on Transaction $ 15,000,000              
iBio CMO [Member] | Eastern [Member]                
Basis of Presentation [Line Items]                
Stock Issued During Period, Shares, New Issues       3,500,000        
Stock Issued During Period, Shares, Acquisitions       10,000,000 10,000,000      
Common Stock, Par or Stated Value Per Share         $ 0.622      
Class Of Warrants Or Rights Exercised       1,784,000        
Class of Warrant or Right, Exercise Price of Warrants or Rights       $ 0.53        
Proceeds From Capitalization Received       $ 15,000,000        
Stock Issued During Period, Value, Acquisitions       $ 7,200,000